BCAS2 Monoklonaler Antikörper
BCAS2 Monoklonal Antikörper für WB, IF/ICC, Indirect ELISA
Wirt / Isotyp
Maus / IgG1
Getestete Reaktivität
human, Maus, Ratte
Anwendung
WB, IF/ICC, Indirect ELISA
Konjugation
Unkonjugiert
CloneNo.
2A12G1
Kat-Nr. : 68003-1-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
68003-1-PBS bindet in WB, IF/ICC, Indirect ELISA BCAS2 und zeigt Reaktivität mit human, Maus, Ratten
| Getestete Reaktivität | human, Maus, Ratte |
| Wirt / Isotyp | Maus / IgG1 |
| Klonalität | Monoklonal |
| Typ | Antikörper |
| Immunogen | BCAS2 fusion protein Ag21309 |
| Vollständiger Name | breast carcinoma amplified sequence 2 |
| Berechnetes Molekulargewicht | 26 kDa |
| Beobachtetes Molekulargewicht | 28 kDa |
| GenBank-Zugangsnummer | BC005285 |
| Gene symbol | BCAS2 |
| Gene ID (NCBI) | 10286 |
| Konjugation | Unkonjugiert |
| Form | Liquid |
| Reinigungsmethode | Protein-G-Reinigung |
| Lagerungspuffer | PBS only |
| Lagerungsbedingungen | Store at -80°C. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
Breast carcinoma amplified sequence 2 (BCAS2) is preferentially known as pre-mRNA splicing factor SPF27 and was originally characterized as an up-regulated gene by amplification in human breast cancer cells. BCAS2 has been shown to be involved in DNA damage repair through the replication protein A (RPA) complex.









